Your browser doesn't support javascript.
loading
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.
Mediani, Laura; Gibellini, Federica; Bertacchini, Jessika; Frasson, Chiara; Bosco, Raffaella; Accordi, Benedetta; Basso, Giuseppe; Bonora, Massimo; Calabrò, Maria Luisa; Mattiolo, Adriana; Sgarbi, Gianluca; Baracca, Alessandra; Pinton, Paolo; Riva, Giovanni; Rampazzo, Enrico; Petrizza, Luca; Prodi, Luca; Milani, Daniela; Luppi, Mario; Potenza, Leonardo; De Pol, Anto; Cocco, Lucio; Capitani, Silvano; Marmiroli, Sandra.
  • Mediani L; Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Modena, Italy.
  • Gibellini F; Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Modena, Italy.
  • Bertacchini J; Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Modena, Italy.
  • Frasson C; Department of Morphology, Surgery and Experimental Medicine, Section of Anatomy and Histology and LTTA Center, University of Ferrara, Ferrara, Italy.
  • Bosco R; Department of Woman's and Child's Health and Institute of Pediatric Research - Città della Speranza Foundation, University of Padova, Padova, Italy.
  • Accordi B; Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Modena, Italy.
  • Basso G; Department of Woman's and Child's Health and Institute of Pediatric Research - Città della Speranza Foundation, University of Padova, Padova, Italy.
  • Bonora M; Department of Woman's and Child's Health and Institute of Pediatric Research - Città della Speranza Foundation, University of Padova, Padova, Italy.
  • Calabrò ML; Department of Morphology, Surgery and Experimental Medicine Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.
  • Mattiolo A; Immunology and Molecular Oncology, Veneto Institute of Oncology, IOV IRCCS, Padova, Italy.
  • Sgarbi G; Immunology and Molecular Oncology, Veneto Institute of Oncology, IOV IRCCS, Padova, Italy.
  • Baracca A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Pinton P; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Riva G; Department of Morphology, Surgery and Experimental Medicine Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.
  • Rampazzo E; Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
  • Petrizza L; Department of Chemistry, University of Bologna, Bologna, Italy.
  • Prodi L; Department of Chemistry, University of Bologna, Bologna, Italy.
  • Milani D; Department of Chemistry, University of Bologna, Bologna, Italy.
  • Luppi M; Department of Morphology, Surgery and Experimental Medicine, Section of Anatomy and Histology and LTTA Center, University of Ferrara, Ferrara, Italy.
  • Potenza L; Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
  • De Pol A; Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
  • Cocco L; Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Modena, Italy.
  • Capitani S; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Marmiroli S; Department of Morphology, Surgery and Experimental Medicine, Section of Anatomy and Histology and LTTA Center, University of Ferrara, Ferrara, Italy.
Oncotarget ; 7(5): 5521-37, 2016 Feb 02.
Article en En | MEDLINE | ID: mdl-26575168
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-akt / Linfoma de Efusión Primaria / Serina-Treonina Quinasas TOR / Inhibidores de las Quinasa Fosfoinosítidos-3 / Glucólisis Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-akt / Linfoma de Efusión Primaria / Serina-Treonina Quinasas TOR / Inhibidores de las Quinasa Fosfoinosítidos-3 / Glucólisis Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article